(Date:7/25/2008)...ewswire-FirstCall/ -- Thoratec,Corporation (Nasdaq...l,circulatory support therapies to save, support a... will report its operating results for the second,...rsday, July 31., The company will hold a conferen...ting activities to all interested parties at 1:30 ...
(Date:7/25/2008)...nsumers tips and encourages them to, ,Speak Up,(T...July 25 /PRNewswire-USNewswire/ -- The Pennsylvani...l Patient Safety Day" which,is a national effort t...pate fully in their healthcare by asking questions...ery or illness., "We understand the important rol...
(Date:7/25/2008)...ing Exclusivity Begins -, CORONA, Calif., July 25... Inc. (NYSE: WPI ), a leading specialty pharmaceu... has commenced commercial,shipment of its Omeprazo...g,strength from its Davie, Florida manufacturing f...s 180 days of marketing exclusivity for being the,...
(Date:7/25/2008)...iance to be presented at Fenway Park ... 25 /PRNewswire/ -- CVS/pharmacy announced today,t... million in just 21 days,through its annual in-sto...the seventh year of the annual fundraising effort ...or ALS research. This year,s fundraiser took,place...
Breaking Medicine News(10 mins):Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2(Date:7/24/2008)... NEW ORLEANS, July 24 /PRNewswire-USNewswire/...eloped for mental illnesses, according to a new,re...cused on the,devastating effects that mental illne.... Nationwide, mental illness affects nearly 60 mil...rmaceutical Research and Manufacturers,of America ...
(Date:7/24/2008)... SOPHIA ANTIPOLIS, France, July 24 /PRNewswir...oday announced the top-line results from the 52-we...following the completion of,the 301 phase 3 study ...d,safety findings and efficacy was maintained for ... the patients, global assessment scale. In,additio...
(Date:7/23/2008)... BOSTON, July 23 /- FluoroPharma... imaging agents for the Positron Emission Tomograp...s for BFPET, its novel,Fluorine-18 labeled tracer ...harma,s second cardiovascular product to complete ...ging agent, designed to assess the blood flow in t...
(Date:7/22/2008)... BRISBANE, Australia, July 22 /PRNewswire-Fir...ded late yesterday, the Board of Progen,Pharmaceut...nced that it,had discontinued the PI-88 phase 3 st...c direction to develop its existing portfolio of c...uire additional compounds and,opportunities throug...
Breaking Medicine Technology:More Than 300 New Medicines Being Developed for Mental Illnesses 2More Than 300 New Medicines Being Developed for Mental Illnesses 3More Than 300 New Medicines Being Developed for Mental Illnesses 4NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 3NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 4FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 6856 1Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 6856 2Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 6856 3Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 6856 4Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 6856 5Human safety prosperity depend on better ocean observing system 3A Scientists 1319 1Human safety prosperity depend on better ocean observing system 3A Scientists 1319 2Human safety prosperity depend on better ocean observing system 3A Scientists 1319 3Human safety prosperity depend on better ocean observing system 3A Scientists 1319 4Human safety prosperity depend on better ocean observing system 3A Scientists 1319 5Human safety prosperity depend on better ocean observing system 3A Scientists 1319 6Human safety prosperity depend on better ocean observing system 3A Scientists 1319 7Human safety prosperity depend on better ocean observing system 3A Scientists 1319 8Age burden divorce and heavy tea consumption are significant risk factors for erosive esophagitis 6850 1Dr Dello Russo Introduces the New EYE Q Lasik 901 1... June 15, 2007-Active Biotech (OMX Nordic: ACTI) p... at the annual EULAR (The,European League Against ...ular.org/">www.eular.org ) conference, June,13-16...t I-3D has a,significant inhibitory effect on dise...atoid arthritis (RA)", commented Sven,André...
...ival Benefit Demonstrated for an AI Over Tamoxifen...07: Analysis of the entire,population of a single ...st cancer can be significantly improved by switchi...alysis of the,Arimidex,-,Nolvadex 95, (ARNO 95) s...Oncology, confirms that postmenopausal women,who h...
Other Medicine Technology:New Positive Pre-clinical Data for Active Biotech's RA Project I-3D 2Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 2Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 3Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 4Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 5...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: